Literature DB >> 21172307

Translation of 5' terminal oligopyrimidine tract (5'TOP) mRNAs in Aplysia Californica is regulated by the target of rapamycin (TOR).

Margaret Labban1, Wayne S Sossin.   

Abstract

Aplysia californica is a model organism for determining the molecular basis of memory. In this system identified synaptic changes have been closely linked to behavioral memories. Long-term sensitization and long-term synaptic changes between sensory neurons and motor neurons require both gene expression followed by translational control of the newly expressed mRNAs. One important mechanism for translational control is mediated through the target of rapamycin (TOR) and one mechanism downstream of TOR is the translational control of mRNAs containing a 5' terminal oligopyrimidine tract (5'TOP) sequence in their mRNA transcript. These include all ribosomal proteins, elongation factors and a few other translational regulators. TOR regulation of 5'TOP mRNAs in vertebrates is thought to be due to TOR dependent removal of the translational repression mediated by the 5'TOP sequence. Here, we show that this mechanism is similar in Aplysia, whereby Aplysia 5'TOP mRNAs are repressed under basal conditions and this repression is removed by serotonin in a rapamycin-sensitive manner.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21172307     DOI: 10.1016/j.bbrc.2010.12.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Longevity pathways and memory aging.

Authors:  Ilias Gkikas; Dionysia Petratou; Nektarios Tavernarakis
Journal:  Front Genet       Date:  2014-06-04       Impact factor: 4.599

2.  Proteomics Studies on the three Larval Stages of Development and Metamorphosis of Babylonia areolata.

Authors:  Minghui Shen; Guilan Di; Min Li; Jingqiang Fu; Qi Dai; Xiulian Miao; Miaoqin Huang; Weiwei You; Caihuan Ke
Journal:  Sci Rep       Date:  2018-04-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.